Assessment of the In Vitro and In Vivo Antifungal Activity of NSC319726 against Candida auris
ABSTRACT Candida auris is an emerging yeast pathogen of candidemia with the ability to develop resistance to all current antifungal drug classes. Novel antifungal therapies against C. auris are warranted. NSC319726 is a thiosemicarbazone with an inhibitory effect on fungal ribosome biogenesis that h...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Microbiology
2021-12-01
|
Series: | Microbiology Spectrum |
Subjects: | |
Online Access: | https://journals.asm.org/doi/10.1128/Spectrum.01395-21 |